Keywords: ABC294640, 3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide; AIPC, androgen independent prostate cancer; ADT, androgen deprivation therapy; DMSO, dimethyl sulfoxide; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromid
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Prostate Specific Antigen Working Group Guidelines on Prostate Specific Antigen Doubling Time
Keywords: prostatic neoplasms; prostate-specific antigen; consensus; clinical trials as topic; biological markersADT, androgen deprivation therapy; AIPC, androgen independent prostate cancer; PSA, prostate specific antigen; PSADT, prostate specific antigen doubling
Finnish Multicenter Study Comparing Intermittent to Continuous Androgen Deprivation for Advanced Prostate Cancer: Interim Analysis of Prognostic Markers Affecting Initial Response to Androgen Deprivation
Keywords: tumor burden; testosterone; prostatic neoplasmsADR, adverse drug reaction; ADS, androgen deprivation syndrome; ADT, androgen deprivation therapy; AIPC, androgen independent prostate cancer; ALP, alkaline phosphatase; CAD, continuous androgen deprivation;
The Case for Secondary Hormonal Therapies in the Chemotherapy Age
Keywords: prostate; prostatic neoplasms; androgen antagonists; ketoconazole; adrenal cortex hormonesAAWD, antiandrogen withdrawal; ADT, androgen deprivation therapy; AIPC, androgen independent prostate cancer; AL, alendronate; AR, androgen receptor; CAB, combined a
Secondary Hormonal Therapy for Advanced Prostate Cancer
Keywords: prostate; prostatic neoplasms; hormones; therapy; carcinomaAAWD, antiandrogen withdrawal; AIPC, androgen independent prostate cancer; AR, androgen receptor; CAB, combined androgen blockade; CPA, cyproterone acetate; DES, diethylstilbestrol; FDA, Food and
Prostate Specific Antigen Doubling Time Calculation: Not as Easy as 1, 2, 4
Keywords: prostate; prostate-specific antigen; prostatic neoplasms; decision support techniquesADT, androgen deprivation therapy; AIPC, androgen independent prostate cancer; EBRT, external beam radiation therapy; HNPC, hormone naïve prostate cancer; HRPC, hormone r